Berna Biotech Pharma GmbH
Our 12 vaccine seed strains
Berna Biotech Pharma has an array of well-established, safe, efficacious and essential vaccines that the world is now needing most urgently. These vaccines are of the kind the former Berna Biotech AG (former Swiss Serum and Vaccine Institute) and Novartis had produced over many years. Those vaccines had a market value of several billion dollars. Berna Biotech Pharma has acquired an important portfolio of 12 of these important vaccine seed strains which are listed below:
Berna Biotech Pharma owns the Edmonston Zagreb strain, which the world's most widely used measles vaccine is based on.
Berna Biotech Pharma owns the Hoshino mumps strain that is known to be highly effective.
Berna Biotech Pharma owns the RA/27 strain that is used also by Glaxo and MSD for the production of Rubella vaccine.
Berna Biotech Pharma owns the Oka strain that is the only strain recommended by the WHO for varicella vaccines production.
Berna Biotech Pharma has access to the seasonal vaccine 4-valent and the pandemic monovalent vaccine strains. It also owns the full documentation and have the production know-how.
Berna Biotech Pharma owns the Pitman Moore Rabies strain, which is the same strain as the one used by Sanofi that is currently the only producer of this vaccine in the Western world.
Berna Biotech Pharma owns the RG-SB strain.
Berna Biotech Pharma has the same clone as the former Berna Biotech.
Berna Biotech Pharma R&D is currently preparing the vaccine seed strain.
Berna Biotech Pharma will use the Oka strain (see Varicella).
Berna Biotech Pharma owns the same strain as the Swiss Serum and Vaccine Institute, which has been the main supplier of the WHO in its eradication campaign.
Berna Biotech Pharma has the know-how to develop and produce the HPV (Human Papilloma Virus) vaccine.